Abstract: A method for operating a driverless vehicle may include receiving, at the driverless vehicle, sensor signals related to operation of the driverless vehicle, and road network data from a road network data store. The method may also include determining a driving corridor within which the driverless vehicle travels according to a trajectory, and causing the driverless vehicle to traverse a road network autonomously according to a path from a first geographic location to a second geographic location. The method may also include determining that an event associated with the path has occurred, and sending communication signals to a teleoperations system including a request for guidance and one or more of sensor data and the road network data. The method may include receiving, at the driverless vehicle, teleoperations signals from the teleoperations system, such that the vehicle controller determines a revised trajectory based at least in part on the teleoperations signals.

Abstract: The present invention relates generally to assays, methods and kits for the prognosis and/or diagnosis of cardiac disorders. The present invention also provides, for example, binding agents to a novel class of circulating troponin biomarkers for use in predicting or diagnosing a cardiac disorder other than myocardial infarction or unstable angina. In addition, the binding agents of the present invention may be used to enhance the sensitivity and false positive performance of cardiac troponins in the prognosis and diagnosis of myocardial infarction.

Abstract: A method for forming an optical fiber preform and fibers drawn from the preform. The method includes forming a soot cladding monolith, inserting a consolidated core cane into the internal cavity, and processing the resulting core-cladding assembly to form a preform. Processing may include exposing the core-cladding assembly to a drying agent and/or dopant precursor, and sintering the core-cladding assembly in the presence of a reducing agent to densify the soot cladding monolith onto the core cane to form a preform. The preform features low hydroxyl content and low sensitivity to hydrogen. Fibers drawn from the preform exhibit low attenuation losses from absorption by the broad band centered near 1380 nm.

Abstract: The present invention relates generally to assays, methods and kits for the prognosis and/or diagnosis of cardiac disorders. The present invention also provides, for example, binding agents to a novel class of circulating cardiac troponin T upstream open reading frame (TnTuORF) peptide biomarkers for use in predicting or diagnosing a cardiac disorder other than myocardial infarction or unstable angina. In addition, the binding agents of the present invention may be used to enhance the sensitivity and false positive performance of cardiac troponins in the prognosis and diagnosis of myocardial infarction.

Abstract: A method for forming an optical fiber preform and fibers drawn from the preform. The method includes forming a soot cladding monolith, inserting a consolidated core cane into the internal cavity, and processing the resulting core-cladding assembly to form a preform. Processing may include exposing the core-cladding assembly to a drying agent and/or dopant precursor, and sintering the core-cladding assembly in the presence of a reducing agent to densify the soot cladding monolith onto the core cane to form a preform. The preform features low hydroxyl content and low sensitivity to hydrogen. Fibers drawn from the preform exhibit low attenuation losses from absorption by the broad band centered near 1380 nm.

Abstract: A method for forming an optical fiber preform and fibers drawn from the preform. The method includes forming a soot cladding monolith, inserting a consolidated core cane into the internal cavity, and processing the resulting core-cladding assembly to form a preform. Processing may include exposing the core-cladding assembly to a drying agent and/or dopant precursor, and sintering the core-cladding assembly in the presence of a reducing agent to densify the soot cladding monolith onto the core cane to form a preform. The preform features low hydroxyl content and low sensitivity to hydrogen. Fibers drawn from the preform exhibit low attenuation losses from absorption by the broad band centered near 1380 nm.

Abstract: The present invention relates generally to assays, methods and kits for the prognosis and/or diagnosis of cardiac disorders. The present invention also provides, for example, binding agents to a novel class of circulating cardiac troponin T upstream open reading frame (TnTuORF) peptide biomarkers for use in predicting or diagnosing a cardiac disorder other than myocardial infarction or unstable angina. In addition, the binding agents of the present invention may be used to enhance the sensitivity and false positive performance of cardiac troponins in the prognosis and diagnosis of myocardial infarction.

Abstract: A method for forming an optical fiber preform and fibers drawn from the preform. The method includes forming a soot cladding monolith, inserting a consolidated core cane into the internal cavity, and processing the resulting core-cladding assembly to form a preform. Processing may include exposing the core-cladding assembly to a drying agent and/or dopant precursor, and sintering the core-cladding assembly in the presence of a reducing agent to densify the soot cladding monolith onto the core cane to form a preform. The preform features low hydroxyl content and low sensitivity to hydrogen. Fibers drawn from the preform exhibit low attenuation losses from absorption by the broad band centered near 1380 nm.

Abstract: The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling characteristics of the composition are a factor. The compositions of the present invention comprise a therapeutically effective amount of one or more GnRH related compound, and a sufficient amount of at least one anti-gelling agents to reduce the gelation of the GnRH related compound. The present invention also provides processes for preparation of a composition of one or more GnRH related compound, wherein the process comprises mixing the GnRH related compound with one or more anti-gelling agents, wherein the anti-gelling agent comprises a medium chain fatty acid salt, or an ester, an ether, or a derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms or is a surface active agent.

Abstract: Systems, compounds and methods for the conversion of C1 carbon compounds to higher carbon compounds useful for the generation of commodity compounds.

Abstract: The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling characteristics of the composition are a factor. The compositions of the present invention comprise a therapeutically effective amount of one or more GnRH related compound, and a sufficient amount of at least one anti-gelling agents to reduce the gelation of the GnRH related compound. The present invention also provides processes for preparation of a composition of one or more GnRH related compound, wherein the process comprises mixing the GnRH related compound with one or more anti-gelling agents, wherein the anti-gelling agent comprises a medium chain fatty acid salt, or an ester, an ether, or a derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms or is a surface active agent.

Abstract: A system for treating wastewater includes an aeration tank having a plurality of air diffusers located within the tank. Air delivery equipment provides air to the tank via air diffusers. An ammonia sensor located near or upstream of the wastewater inlet is used by a controller to measure the ammonia content of the wastewater at the inlet. The controller then modifies the actual airflow provided to the tank based on a prediction of the level of air flow required to fully treat the wastewater before it reaches the outlet and controls the air source to provide the predicted level of air flow.

Abstract: Methods for forming optical fiber preforms are disclosed. According to one embodiment, a method for forming an optical fiber preform includes forming a preform core portion from silica-based glass soot. The silica-based glass soot may include at least one dopant species for altering an index of refraction of the preform core portion. A selective diffusion layer of silica-based glass soot may be formed around the preform core portion to form a soot preform. The selective diffusion layer may have an as-formed density greater than the density of the preform core portion. A diffusing species may be diffused through the selective diffusion layer into the preform core portion. The soot preform may be sintered such that the selective diffusion layer has a barrier density which is greater than the as-formed density and the selective diffusion layer prevents diffusion of the at least one dopant species through the selective diffusion layer.

Abstract: A system and method for electronically evaluating and selecting schools based on user inputs is provided. The system may include a server for receiving and processing information and preferences of a student provided by a user and databases for storing such information. The system may also receive and process information from alumni and other sources to create a profile for a school. An algorithm provided by the system may be used to provide the user a report and custom ranking of schools based on the student information and preferences, and school profiles.

Abstract: Systems, compounds and methods for the conversion of C1 carbon compounds to higher carbon compounds useful for the generation of commodity compounds.

Abstract: The present invention provides compositions of GnRH related compounds that are suitable for oral administration, injectable administration and other forms of administration wherein the gelling characteristics of the composition are a factor. The compositions of the present invention comprise a therapeutically effective amount of one or more GnRH related compound, and a sufficient amount of at least one anti-gelling agents to reduce the gelation of the GnRH related compound. The present invention also provides processes for preparation of a composition of one or more GnRH related compound, wherein the process comprises mixing the GnRH related compound with one or more anti-gelling agents, wherein the anti-gelling agent comprises a medium chain fatty acid salt, or an ester, an ether, or a derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms or is a surface active agent.

Abstract: A finger wipe that fits onto one or two human fingers. The finger wipe can be used as a substitute for cotton balls, swabs, and/or gauzes, or as an oral cleaning device. The finger wipe includes at least one reservoir that contains a composition. The composition may be a liquid or a solid. For example, in one embodiment, the composition may comprise a cleaning solution, a pharmaceutical, or a skin-conditioning agent. The reservoir is constructed such that the reservoir can be ruptured. For instance, in one embodiment, the reservoir may be ruptured by squeezing two fingers together. In this manner, the composition is released when desired for use in conjunction with the finger wipe.

Abstract: A diagnostic test unit is provided. The test unit comprises a stem having a first end and a second end, the stem defining at least one flow channel extending between the first end and the second end. A swab is disposed at the first end of the stem, the swab being configured to collect a test sample derived from a biological source that is suspected of containing an analyte. The test unit also comprises a fluid chamber configured to contain a fluid, wherein the fluid chamber is in fluid communication with the swab via the flow channel. The test unit also comprises a rupturable seal that inhibits leakage of the fluid from the fluid chamber prior to use, and an assay for detecting the presence or absence of the analyte. The assay is in fluid communication with the swab, the flow channel, and the fluid chamber.

Abstract: A self contained diagnostic test device is provided for use in the collection and detection of a biological specimen or the like. The device comprises a tubular swab and reagent dispensing cap component for receiving specimens. The reagent dispensing cap component includes barrel, reagent chamber, and results window subcomponents, and delivers one or more selected reagents to a specimen testing chamber for contacting the collected specimen, upon the rotation of the reagent chamber component.

Abstract: An absorbent article is disclosed having an absorbent with first and second longitudinal sides. A liquid permeable wrapper encloses the absorbent. The wrapper extending laterally outward from each of the first and second longitudinal sides a distance of at least about 10 millimeters to form a pair of fringes. The pair of fringes are capable of being biased upward to form a pair of upstanding side walls when the absorbent article is placed in an undergarment. The upstanding side walls form a pair of reservoirs located adjacent to the absorbent. The reservoirs are capable of retaining body fluid that has run off of the wrapper until the body fluid can be absorbed by the absorbent.